|
1
|
Forte A, Cipollaro M and Galderisi U:
Genetic, epigenetic and stem cell alterations in endometriosis: new
insights and potential therapeutic perspectives. Clin Sci (Lond).
126:123–138. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kobayashi H, Yamada Y, Kanayama S, et al:
The role of iron in the pathogenesis of endometriosis. Gynecol
Endocrinol. 25:39–52. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Munksgaard PS and Blaakaer J: The
association between endometriosis and ovarian cancer: a review of
histological, genetic and molecular alterations. Gynecol Oncol.
124:164–169. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vlahos NF, Kalampokas T and Fotiou S:
Endometriosis and ovarian cancer: a review. Gynecol Endocrinol.
26:213–219. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Congrains A, Kamide K, Ohishi M and Rakugi
H: ANRIL: molecular mechanisms and implications in human health.
Int J Mol Sci. 14:1278–1292. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guo SW: Epigenetics of endometriosis. Mol
Hum Reprod. 15:587–607. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Van Langendonckt A, Casanas-Roux F and
Donnez J: Oxidative stress and peritoneal endometriosis. Fertil
Steril. 77:861–870. 2002.PubMed/NCBI
|
|
8
|
Oner-Iyidoğan Y, Koçak H, Gürdöl F,
Korkmaz D and Buyru F: Indices of oxidative stress in eutopic and
ectopic endometria of women with endometriosis. Gynecol Obstet
Invest. 57:214–217. 2004.PubMed/NCBI
|
|
9
|
Ngô C, Chéreau C, Nicco C, Weill B,
Chapron C and Batteux F: Reactive oxygen species controls
endometriosis progression. Am J Pathol. 175:225–234.
2009.PubMed/NCBI
|
|
10
|
Nezhat F, Datta MS, Hanson V, Pejovic T
and Nezhat C and Nezhat C: The relationship of endometriosis and
ovarian malignancy: a review. Fertil Steril. 90:1559–1570. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kennedy S: Genetics of endometriosis: a
review of the positional cloning approaches. Semin Reprod Med.
21:111–118. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Spuijbroek MD, Dunselman GA, Menheere PP
and Evers JL: Early endometriosis invades the extracellular matrix.
Fertil Steril. 58:929–933. 1992.PubMed/NCBI
|
|
13
|
Worley MJ, Welch WR, Berkowitz RS and Ng
SW: Endometriosis-associated ovarian cancer: a review of
pathogenesis. Int J Mol Sci. 14:5367–5379. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Higashiura Y, Kajihara H, Shigetomi H and
Kobayashi H: Identification of multiple pathways involved in the
malignant transformation of endometriosis (Review). Oncol Lett.
4:3–9. 2012.PubMed/NCBI
|
|
15
|
Mao TL and Shih IM: The roles of ARID1A in
gynecologic cancer. J Gynecol Oncol. 24:376–381. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yamamoto S, Tsuda H, Takano M, Iwaya K,
Tamai S and Matsubara O: PIK3CA mutation is an early event in the
development of endometriosis-associated ovarian clear cell
adenocarcinoma. J Pathol. 225:189–194. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Samartzis EP, Noske A, Dedes KJ, Fink D
and Imesch P: ARID1A mutations and PI3K/AKT pathway alterations in
endometriosis and endometriosis-associated ovarian carcinomas. Int
J Mol Sci. 14:18824–1849. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Maeda D and Shih IeM: Pathogenesis and the
role of ARID1A mutation in endometriosis-related ovarian neoplasms.
Adv Anat Pathol. 20:45–52. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wiegand KC, Shah SP, Al-Agha OM, et al:
ARID1A mutations in endometriosis-associated ovarian carcinomas. N
Engl J Med. 363:1532–1543. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Amemiya S, Sekizawa A, Otsuka J, Tachikawa
T, Saito H and Okai T: Malignant transformation of endometriosis
and genetic alterations of K-ras and microsatellite instability.
Int J Gynaecol Obstet. 86:371–376. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nakayama K, Toki T, Nikaido T, Zhai YL and
Konishi I: Genetic alterations in microsatellite marker sites among
tumor suppressor genes in endometriosis. Gynecol Obstet Invest.
51:240–242. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fuseya C, Horiuchi A, Hayashi A, et al:
Involvement of pelvic inflammation-related mismatch repair
abnormalities and microsatellite instability in the malignant
transformation of ovarian endometriosis. Hum Pathol. 43:1964–1972.
2012. View Article : Google Scholar
|
|
23
|
Ali-Fehmi R, Khalifeh I, Bandyopadhyay S,
et al: Patterns of loss of heterozygosity at 10q23.3 and
microsatellite instability in endometriosis, atypical
endometriosis, and ovarian carcinoma arising in association with
endometriosis. Int J Gynecol Pathol. 25:223–229. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gogusev J, Bouquet de Jolinière J, Telvi
L, et al: Genetic abnormalities detected by comparative genomic
hybridization in a human endometriosis-derived cell line. Mol Hum
Reprod. 6:821–827. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang W, Zhang Y, Fu F and Li R:
High-resolution array-comparative genomic hybridization profiling
reveals 20q13.33 alterations associated with ovarian endometriosis.
Gynecol Endocrinol. 29:603–607. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Saare M, Sõritsa D, Vaidla K, et al: No
evidence of somatic DNA copy number alterations in eutopic and
ectopic endometrial tissue in endometriosis. Hum Reprod.
27:1857–1864. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sato N, Tsunoda H, Nishida M, et al: Loss
of heterozygosity on 10q23.3 and mutation of the tumor suppressor
gene PTEN in benign endometrial cyst of the ovary: possible
sequence progression from benign endometrial cyst to endometrioid
carcinoma and clear cell carcinoma of the ovary. Cancer Res.
60:7052–7056. 2000.
|
|
28
|
Obata K and Hoshiai H: Common genetic
changes between endometriosis and ovarian cancer. Gynecol Obstet
Invest. 50(Suppl 1): 39–43. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu B, Hamada S, Kusuki I, Itoh R and
Kitawaki J: Possible involvement of loss of heterozygosity in
malignant transformation of ovarian endometriosis. Gynecol Oncol.
120:239–246. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Thomas EJ and Campbell IG: Molecular
genetic defects in endometriosis. Gynecol Obstet Invest. 50(Suppl
1): 44–50. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Painter JN, Anderson CA, Nyholt DR, et al:
Genome-wide association study identifies a locus at 7p15.2
associated with endometriosis. Nat Genet. 43:51–54. 2011.
View Article : Google Scholar
|
|
32
|
Jiang X, Hitchcock A, Bryan EJ, et al:
Microsatellite analysis of endometriosis reveals loss of
heterozygosity at candidate ovarian tumor suppressor gene loci.
Cancer Res. 56:3534–3539. 1996.PubMed/NCBI
|
|
33
|
Silveira CG, Abrão MS, Dias JA Jr, et al:
Common chromosomal imbalances and stemness-related protein
expression markers in endometriotic lesions from different
anatomical sites: the potential role of stem cells. Hum Reprod.
27:3187–3197. 2012. View Article : Google Scholar
|
|
34
|
Son JW, Jeong KJ, Jean WS, et al:
Genome-wide combination profiling of DNA copy number and
methylation for deciphering biomarkers in non-small cell lung
cancer patients. Cancer Lett. 311:29–37. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Goumenou AG, Arvanitis DA, Matalliotakis
IM, Koumantakis EE and Spandidos DA: Microsatellite DNA assays
reveal an allelic imbalance in p16(Ink4), GALT, p53, and APOA2 loci
in patients with endometriosis. Fertil Steril. 75:160–165. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Govatati S, Kodati VL, Deenadayal M,
Chakravarty B, Shivaji S and Bhanoori M: Mutations in the PTEN
tumor gene and risk of endometriosis: a case-control study. Hum
Reprod. 29:324–336. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dun EC, Taylor RN and Wieser F: Advances
in the genetics of endometriosis. Genome Med. 2:752010. View Article : Google Scholar
|
|
38
|
Kurman RJ and Shih IeM: The origin and
pathogenesis of epithelial ovarian cancer: a proposed unifying
theory. Am J Surg Pathol. 34:433–443. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Noack F, Schmidt H, Buchweitz O, Malik E
and Horny HP: Genomic imbalance and onco-protein expression of
ovarian endometrioid adenocarcinoma arisen in an endometriotic
cyst. Anticancer Res. 24:151–154. 2004.PubMed/NCBI
|
|
40
|
Pellegrini C, Gori I, Achtari C, et al:
The expression of estrogen receptors as well as GREB1, c-MYC, and
cyclin D1, estrogen-regulated genes implicated in proliferation, is
increased in peritoneal endometriosis. Fertil Steril. 98:1200–1208.
2012. View Article : Google Scholar
|
|
41
|
Catasús L, Bussaglia E, Rodrguez I, et al:
Molecular genetic alterations in endometrioid carcinomas of the
ovary: similar frequency of beta-catenin abnormalities but lower
rate of microsatellite instability and PTEN alterations than in
uterine endometrioid carcinomas. Hum Pathol. 35:1360–1368.
2004.
|
|
42
|
Stewart CJ, Walsh MD, Budgeon CA, Crook ML
and Buchanan DB: Immunophenotypic analysis of ovarian endometrioid
adenocarcinoma: correlation with KRAS mutation and the presence of
endometriosis. Pathology. 45:559–566. 2013. View Article : Google Scholar
|
|
43
|
Shaco-Levy R, Sharabi S, Benharroch D,
Piura B and Sion-Vardy N: Matrix metalloproteinases 2 and 9,
E-cadherin, and beta-catenin expression in endometriosis, low-grade
endometrial carcinoma and non-neoplastic eutopic endometrium. Eur J
Obstet Gynecol Reprod Biol. 139:226–232. 2008. View Article : Google Scholar
|
|
44
|
Hadjihannas MV and Behrens J: CIN By WNT:
growth pathways, mitotic control and chromosomal instability in
cancer. Cell Cycle. 5:2077–2081. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bau DT, Hsieh YY, Wan L, et al:
Polymorphism of XRCC1 codon arg 399 Gln is associated with higher
susceptibility to endometriosis. Chin J Physiol. 50:326–329.
2007.PubMed/NCBI
|
|
46
|
Hsieh YY, Bau DT, Chang CC, Tsai CH, Chen
CP and Tsai FJ: XRCC4 codon 247*A and XRCC4 promoter −1394*T
related genotypes but not XRCC4 intron 3 gene polymorphism are
associated with higher susceptibility for endometriosis. Mol Reprod
Dev. 75:946–951. 2008.
|
|
47
|
Carvalho LF, Abrão MS, Biscotti C, Sharma
R, Nutter B and Falcone T: Oxidative cell injury as a predictor of
endometriosis progression. Reprod Sci. 20:688–698. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Miao J, Zhang X, Tang QL, Wang XY and Kai
L: Prediction value of XRCC 1 gene polymorphism on the survival of
ovarian cancer treated by adjuvant chemotherapy. Asian Pac J Cancer
Prev. 13:5007–5010. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sáinz de la Cuesta R, Izquierdo M,
Cañamero M, Granizo JJ and Manzarbeitia F: Increased prevalence of
p53 overexpression from typical endometriosis to atypical
endometriosis and ovarian cancer associated with endometriosis. Eur
J Obstet Gynecol Reprod Biol. 113:87–93. 2004.PubMed/NCBI
|
|
50
|
Fauvet R, Poncelet C, Hugol D, Lavaur A,
Feldmann G and Daraï E: Expression of apoptosis-related proteins in
endometriomas and benign and malignant ovarian tumours. Virchows
Arch. 443:38–43. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Nezhat F, Cohen C, Rahaman J, Gretz H,
Cole P and Kalir T: Comparative immunohistochemical studies of
bcl-2 and p53 proteins in benign and malignant ovarian
endometriotic cysts. Cancer. 94:2935–2940. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kim SH, Choi YM, Lee GH, et al:
Association between susceptibility to advanced stage endometriosis
and the genetic polymorphisms of aryl hydrocarbon receptor
repressor and glutathione-S-transferase T1 genes. Hum Reprod.
22:1866–1870. 2007. View Article : Google Scholar
|
|
53
|
Cramer DW, Hornstein MD, Ng WG and
Barbieri RL: Endometriosis associated with the N314D mutation of
galactose-1-phosphate uridyl transferase (GALT). Mol Hum Reprod.
2:149–152. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Stefansson H, Einarsdottir A, Geirsson RT,
et al: Endometriosis is not associated with or linked to the GALT
gene. Fertil Steril. 76:1019–1022. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
He C, Song Y, He X, Zhang W and Liao L: No
association of endometriosis with galactose-1-phosphate uridyl
transferase mutations in a Chinese population. Environ Mol Mutagen.
47:307–309. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Babu KA, Reddy NG, Deendayal M, Kennedy S
and Shivaji S: GSTM1, GSTT1 and CYP1A1 detoxification gene
polymorphisms and their relationship with advanced stages of
endometriosis in South Indian women. Pharmacogenet Genomics.
15:167–172. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Hsieh YY, Chang CC, Tsai FJ, Lin CC, Chen
JM and Tsai CH: Glutathione S-transferase M1*null genotype but not
myeloperoxidase promoter G-463A polymorphism is associated with
higher susceptibility to endometriosis. Mol Hum Reprod. 10:713–717.
2004.
|
|
58
|
Arvanitis DA, Goumenou AG, Matalliotakis
IM, Koumantakis EE and Spandidos DA: Low-penetrance genes are
associated with increased susceptibility to endometriosis. Fertil
Steril. 76:1202–1206. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Baranova H, Canis M, Ivaschenko T, et al:
Possible involvement of arylamine N-acetyltransferase 2,
glutathione S-transferases M1 and T1 genes in the development of
endometriosis. Mol Hum Reprod. 5:636–641. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Baranova H, Bothorishvilli R, Canis M, et
al: Glutathione S-transferase M1 gene polymorphism and
susceptibility to endometriosis in a French population. Mol Hum
Reprod. 3:775–780. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wu CH, Guo CY, Yang JG, et al:
Polymorphisms of dioxin receptor complex components and
detoxification-related genes jointly confer susceptibility to
advanced-stage endometriosis in the taiwanese han population. Am J
Reprod Immunol. 67:160–168. 2012. View Article : Google Scholar
|
|
62
|
Nakago S, Hadfield RM, Zondervan KT, et
al: Association between endometriosis and N-acetyl transferase 2
polymorphisms in a UK population. Mol Hum Reprod. 7:1079–1083.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Vestergaard AL, Thorup K, Knudsen UB, et
al: Oncogenic events associated with endometrial and ovarian
cancers are rare in endometriosis. Mol Hum Reprod. 17:758–761.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Nakayama K, Toki T, Zhai YL, et al:
Demonstration of focal p53 expression without genetic alterations
in endometriotic lesions. Int J Gynecol Pathol. 20:227–231. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Akahane T, Sekizawa A, Purwosunu Y,
Nagatsuka M and Okai T: The role of p53 mutation in the carcinomas
arising from endometriosis. Int J Gynecol Pathol. 26:345–351. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Stewart CJ, Leung Y, Walsh MD, Walters RJ,
Young JP and Buchanan DD: KRAS mutations in ovarian low-grade
endometrioid adenocarcinoma: association with concurrent
endometriosis. Hum Pathol. 43:1177–1183. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Christie M and Oehler MK: Molecular
pathology of epithelial ovarian cancer. J Br Menopause Soc.
12:57–63. 2006. View Article : Google Scholar
|
|
68
|
Willner J, Wurz K, Allison KH, et al:
Alternate molecular genetic pathways in ovarian carcinomas of
common histological types. Hum Pathol. 38:607–613. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Yamamoto S, Tsuda H, Honda K, et al: ACTN4
gene amplification and actinin-4 protein overexpression drive
tumour development and histological progression in a high-grade
subset of ovarian clear-cell adenocarcinomas. Histopathology.
60:1073–1083. 2012. View Article : Google Scholar
|
|
70
|
Wu RC, Ayhan A, Maeda D, et al: Frequent
somatic mutations of the telomerase reverse transcriptase promoter
in ovarian clear cell carcinoma but not in other major types of
gynaecological malignancy. J Pathol. 232:473–481. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Prefumo F, Venturini PL and Fulcheri E:
Analysis of p53 and c-erbB-2 expression in ovarian endometrioid
carcinomas arising in endometriosis. Int J Gynecol Pathol.
22:83–88. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Ying TH, Tseng CJ, Tsai SJ, et al:
Association of p53 and CDKN1A genotypes with endometriosis.
Anticancer Res. 31:4301–4306. 2011.PubMed/NCBI
|
|
73
|
Skirnisdottir I and Seidal T: Association
of p21, p21/p27 and p21/p53 status to histological subtypes and
prognosis in low-stage epithelial ovarian cancer. Cancer Genomics
Proteomics. 10:27–34. 2013.PubMed/NCBI
|
|
74
|
Lee YH, Heo JH, Kim TH, et al:
Significance of cell cycle regulatory proteins as malignant and
prognostic biomarkers in ovarian epithelial tumors. Int J Gynecol
Pathol. 30:205–217. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Yamamoto S, Tsuda H, Miyai K, Takano M,
Tamai S and Matsubara O: Accumulative copy number increase of MET
drives tumor development and histological progression in a subset
of ovarian clear-cell adenocarcinomas. Mod Pathol. 25:122–130.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Otsuka J, Okuda T, Sekizawa A, et al:
K-ras mutation may promote carcinogenesis of endometriosis leading
to ovarian clear cell carcinoma. Med Electron Microsc. 37:188–192.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Govatati S, Deenadayal M, Shivaji S and
Bhanoori M: Mitochondrial displacement loop alterations are
associated with endometriosis. Fertil Steril. 99:1980–1986.e9.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Hsu CC, Lee HC and Wei YH: Mitochondrial
DNA alterations and mitochondrial dysfunction in the progression of
hepatocellular carcinoma. World J Gastroenterol. 19:8880–8886.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Govatati S, Tipirisetti NR, Perugu S, et
al: Mitochondrial genome variations in advanced stage
endometriosis: a study in South Indian population. PLoS One.
7:e406682012. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Cho S, Lee YM, Choi YS, et al:
Mitochondria DNA polymorphisms are associated with susceptibility
to endometriosis. DNA Cell Biol. 31:317–322. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Kao SH, Huang HC, Hsieh RH, Chen SC, Tsai
MC and Tzeng CR: Oxidative damage and mitochondrial DNA mutations
with endometriosis. Ann NY Acad Sci. 1042:186–194. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Colón-Díaz M, Báez-Vega P, García M, et
al: HDAC1 and HDAC2 are differentially expressed in endometriosis.
Reprod Sci. 19:483–492. 2012.
|
|
83
|
Cakmak H and Taylor HS: Implantation
failure: molecular mechanisms and clinical treatment. Hum Reprod
Update. 17:242–253. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Nasu K, Kawano Y, Tsukamoto Y, et al:
Aberrant DNA methylation status of endometriosis: epigenetics as
the pathogenesis, biomarker and therapeutic target. J Obstet
Gynaecol Res. 37:683–695. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Kawano Y, Nasu K, Li H, et al: Application
of the histone deacetylase inhibitors for the treatment of
endometriosis: histone modifications as pathogenesis and novel
therapeutic target. Hum Reprod. 26:2486–2498. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Wu Y, Strawn E, Basir Z, Halverson G and
Guo SW: Aberrant expression of deoxyribonucleic acid
methyltransferases DNMT1, DNMT3A, and DNMT3B in women with
endometriosis. Fertil Steril. 87:24–32. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Izawa M, Taniguchi F, Terakawa N and
Harada T: Epigenetic aberration of gene expression in
endometriosis. Front Biosci (Elite Ed). 5:900–910. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Khan MA, Sengupta J, Mittal S and Ghosh D:
Genome-wide expressions in autologous eutopic and ectopic
endometrium of fertile women with endometriosis. Reprod Biol
Endocrinol. 10:842012. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Kobayashi H, Uekuri C and Shigetomi H:
Towards an understanding of the molecular mechanism of
endometriosis: unbalancing epithelial-stromal genetic conflict.
Gynecol Endocrinol. 30:7–15. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Peltomäki P and Bützow R: Pathogenesis of
endometriosis and its relationship to gynecological cancers.
Epigenomics. 3:689–690. 2011.PubMed/NCBI
|
|
91
|
Tiberi F, Tropea A, Romani F, Apa R,
Marana R and Lanzone A: Prokineticin 1, homeobox A10, and
progesterone receptor messenger ribonucleic acid expression in
primary cultures of endometrial stromal cells isolated from
endometrium of healthy women and from eutopic endometrium of women
with endometriosis. Fertil Steril. 94:2558–2563. 2010. View Article : Google Scholar
|
|
92
|
Vinatier D, Cosson M and Dufour P: Is
endometriosis an endometrial disease? Eur J Obstet Gynecol Reprod
Biol. 91:113–125. 2000. View Article : Google Scholar
|
|
93
|
Nyholt DR, Low SK, Anderson CA, et al:
Genome-wide association meta-analysis identifies new endometriosis
risk loci. Nat Genet. 44:1355–1359. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Calicchio R, Doridot L, Miralles F, Méhats
C and Vaiman D: DNA methylation, an epigenetic mode of gene
expression regulation in reproductive science. Curr Pharm Des. Jul
19–2013.(Epub ahead of print).
|
|
95
|
Kobayashi H, Iwai K, Niiro E, Morioka S
and Yamada Y: Fetal programming theory: Implication for the
understanding of endometriosis. Hum Immunol. 75:208–217. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
McCarty CA, Berg RL, Welter JD, Kitchner
TE and Kemnitz JW: A novel gene-environment interaction involved in
endometriosis. Int J Gynaecol Obstet. 116:61–63. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Missmer SA, Hankinson SE, Spiegelman D,
Barbieri RL, Michels KB and Hunter DJ: In utero exposures and the
incidence of endometriosis. Fertil Steril. 82:1501–1508. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Parazzini F, Cipriani S, Bravi F, et al: A
metaanalysis on alcohol consumption and risk of endometriosis. Am J
Obstet Gynecol. 209:106.e1–e10. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Andolf E, Thorsell M and Källén K:
Caesarean section and risk for endometriosis: a prospective cohort
study of Swedish registries. BJOG. 120:1061–1065. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Kvaskoff M, Bijon A, Clavel-Chapelon F,
Mesrine S and Boutron-Ruault MC: Childhood and adolescent exposures
and the risk of endometriosis. Epidemiology. 24:261–269. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Missmer SA, Chavarro JE, Malspeis S, et
al: A prospective study of dietary fat consumption and
endometriosis risk. Hum Reprod. 25:1528–535. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Vitonis AF, Baer HJ, Hankinson SE, Laufer
MR and Missmer SA: A prospective study of body size during
childhood and early adulthood and the incidence of endometriosis.
Hum Reprod. 25:1325–1334. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Guo SW, Simsa P, Kyama CM, et al:
Reassessing the evidence for the link between dioxin and
endometriosis: from molecular biology to clinical epidemiology. Mol
Hum Reprod. 15:609–624. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Marino JL, Holt VL, Chen C and Davis S:
Lifetime occupational history and risk of endometriosis. Scand J
Work Environ Health. 35:233–240. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Nagle CM, Bell TA, Purdie DM, et al:
Relative weight at ages 10 and 16 years and risk of endometriosis:
a case-control analysis. Hum Reprod. 24:1501–1506. 2009.PubMed/NCBI
|
|
106
|
Kavoussi SK, West BT, Taylor GW and
Lebovic DI: Periodontal disease and endometriosis: analysis of the
National Health and Nutrition Examination Survey. Fertil Steril.
91:335–342. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Buck Louis GM, Hediger ML and Peña JB:
Intrauterine exposures and risk of endometriosis. Hum Reprod.
22:3232–3236. 2007.
|
|
108
|
Kvaskoff M, Mesrine S, Clavel-Chapelon F
and Boutron-Ruault MC: Endometriosis risk in relation to naevi,
freckles and skin sensitivity to sun exposure: the French E3N
cohort. Int J Epidemiol. 38:1143–1. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Kobayashi H, Higashiura Y, Shigetomi H and
Kajihara H: Pathogenesis of endometriosis: The role of initial
infection and subsequent sterile inflammation (Review). Mol Med
Rep. 9:9–15. 2014.PubMed/NCBI
|
|
110
|
Prá D, Franke SI, Henriques JA and Fenech
M: Iron and genome stability: an update. Mutat Res. 733:92–99.
2012.PubMed/NCBI
|
|
111
|
Yamada Y, Shigetomi H, Onogi A, et al:
Redox-active iron-induced oxidative stress in the pathogenesis of
clear cell carcinoma of the ovary. Int J Gynecol Cancer.
21:1200–1207. 2011.PubMed/NCBI
|
|
112
|
Loi M, Del Savio L and Stupka E: Social
epigenetics and equality of opportunity. Public Health Ethics.
6:142–153. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Yara S, Lavoie JC, Beaulieu JF, et al:
Iron-ascorbate-mediated lipid peroxidation causes epigenetic
changes in the antioxidant defense in intestinal epithelial cells:
impact on inflammation. PLoS One. 8:e634562013. View Article : Google Scholar
|
|
114
|
Kim HY, Cho S, Choi YS, et al:
Cyclooxygenase-2 (COX-2) gene-765G/C polymorphism and
advanced-stage endometriosis in Korean women. Am J Reprod Immunol.
68:238–243. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Barbosa CP, Teles JS, Lerner TG, et al:
Genetic association study of polymorphisms FOXP3 and FCRL3 in women
with endometriosis. Fertil Steril. 97:1124–1128. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Bianco B, Teles JS, Lerner TG, Vilarino
FL, Christofolini DM and Barbosa CP: Association of FCRL3 −169T/C
polymorphism with endometriosis and identification of a protective
haplotype against the development of the disease in Brazilian
population. Hum Immunol. 72:774–778. 2011.
|
|
117
|
Teles JS, Bianco B, Vilarino FL, André GM,
Christofolini DM and Barbosa CP: Association of FCRL3 C-169T
promoter single-nucleotide polymorphism with idiopathic infertility
and infertility-related endometriosis. J Reprod Immunol.
89:212–215. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Kitawaki J, Koshiba H, Kitaoka Y, et al:
Interferon-gamma gene dinucleotide (CA) repeat and interleukin-4
promoter region (-590C/T) polymorphisms in Japanese patients with
endometriosis. Hum Reprod. 19:1765–1769. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Kim JJ, Choi YM, Hwang SS, et al:
Association of the interferon-γ gene (CA)n repeat polymorphism with
endometriosis. BJOG. 118:1061–1066. 2011.
|
|
120
|
Rozati R, Vanaja MC and Nasaruddin K:
Genetic contribution of the interferon gamma dinucleotide-repeat
polymorphism in South Indian women with endometriosis. J Obstet
Gynaecol Res. 36:825–831. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Adachi S, Tajima A, Quan J, et al:
Meta-analysis of genome-wide association scans for genetic
susceptibility to endometriosis in Japanese population. J Hum
Genet. 55:816–821. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Gallegos-Arreola MP, Figuera-Villanueva
LE, Puebla-Pérez AM, Montoya-Fuentes H, Suarez-Rincon AE and
Zúñiga-González GM: Association of TP53 gene codon 72 polymorphism
with endometriosis in Mexican women. Genet Mol Res. 11:1401–1408.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
D’Amora P, Sato H, Girão MJ, Silva ID and
Schor E: Polymorphisms in exons 1B and 1C of the type I
interleukin-1 receptor gene in patients with endometriosis. Am J
Reprod Immunol. 56:178–184. 2006.PubMed/NCBI
|
|
124
|
Hsieh YY, Chang CC, Tsai FJ, Hsu CM, Lin
CC and Tsai CH: Interleukin-2 receptor beta (IL-2R beta)-627*C
homozygote but not IL-12R beta 1 codon 378 or IL-18 105
polymorphism is associated with higher susceptibility to
endometriosis. Fertil Steril. 84:510–512. 2005.PubMed/NCBI
|
|
125
|
Li J, Chen Y, Wei S, et al: Tumor necrosis
factor and interleukin-6 gene polymorphisms and endometriosis risk
in Asians: a systematic review and meta-analysis. Ann Hum Genet.
Dec 6–2013.(Epub ahead of print).
|
|
126
|
Kitawaki J, Kiyomizu M, Obayashi H, et al:
Synergistic effect of interleukin-6 promoter (IL6 −634C/G) and
intercellular adhesion molecule-1 (ICAM-1 469K/E) gene
polymorphisms on the risk of endometriosis in Japanese women. Am J
Reprod Immunol. 56:267–274. 2006.
|
|
127
|
Fan W, Li S, Chen Q, Huang Z, Ma Q and
Xiao Z: Association between interleukin-10 promoter polymorphisms
and endometriosis: a meta-analysis. Gene. 515:49–55. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Riiskjaer M, Nielsen K, Steffensen R,
Erikstrup C, Forman A and Kruse C: Association of interleukin-10
promoter polymorphism and endometriosis. Am J Reprod Immunol.
65:13–19. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Juo SH, Wu R, Lin CS, Wu MT, Lee JN and
Tsai EM: A functional promoter polymorphism in interleukin-10 gene
influences susceptibility to endometriosis. Fertil Steril.
92:1228–1233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Xie J, Wang S, He B, et al: Association of
estrogen receptor alpha and interleukin-10 gene polymorphisms with
endometriosis in a Chinese population. Fertil Steril. 92:54–60.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Zhang X, Hei P, Deng L and Lin J:
Interleukin-10 gene promoter polymorphisms and their protein
production in peritoneal fluid in patients with endometriosis. Mol
Hum Reprod. 13:135–140. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Hsieh YY, Chang CC, Tsai FJ, Lin CC, Tai
CT and Ho M: Association of an A allele for interleukin-10 −627
gene promoter polymorphism with higher susceptibility to
endometriosis. J Reprod Med. 48:735–738. 2003.
|
|
133
|
Kitawaki J, Obayashi H, Ohta M, et al:
Genetic contribution of the interleukin-10 promoter polymorphism in
endometriosis susceptibility. Am J Reprod Immunol. 47:12–18. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Gan XL, Lin YH, Zhang Y, Yu TH and Hu LN:
Association of an interleukin-16 gene polymorphism with the risk
and pain phenotype of endometriosis. DNA Cell Biol. 29:663–667.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Ayaz L, Çelik SK, Çayan F, Aras-Ateş N and
Tamer L: Functional association of interleukin-18 gene -607 C/A
promoter polymorphisms with endometriosis. Fertil Steril.
95:298–300. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Kitawaki J, Xu B, Ishihara H, et al:
Association of killer cell immunoglobulin-like receptor genotypes
with susceptibility to endometriosis. Am J Reprod Immunol.
58:481–486. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Bianco B, Lerner TG, Trevisan CM,
Cavalcanti V, Christofolini DM and Barbosa CP: The nuclear
factor-κB functional promoter polymorphism is associated with
endometriosis and infertility. Hum Immunol. 73:1190–1193. 2012.
|
|
138
|
Zhou B, Rao L, Peng Y, et al: A functional
promoter polymorphism in NFKB1 increases susceptibility to
endometriosis. DNA Cell Biol. 29:235–239. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Kim H, Ku SY, Kim SH, et al: Endothelial
nitric oxide synthase gene Glu298Asp polymorphism is associated
with advanced stage endometriosis. Hum Reprod. 24:2656–2659. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Lakshmi KV, Shetty P, Vottam K, Govindhan
S, Ahmad SN and Hasan Q: Tumor necrosis factor alpha -C850T
polymorphism is significantly associated with endometriosis in
Asian Indian women. Fertil Steril. 94:453–456. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Chae SJ, Kim H, Jee BC, Suh CS, Kim SH and
Kim JG: Tumor necrosis factor (TNF)-TNF receptor gene polymorphisms
and their serum levels in Korean women with endometriosis. Am J
Reprod Immunol. 60:432–439. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Lee GH, Choi YM, Kim SH, et al:
Association of tumor necrosis factor-{alpha} gene polymorphisms
with advanced stage endometriosis. Hum Reprod. 23:977–981.
2008.
|
|
143
|
Asghar T, Yoshida S, Kennedy S, et al: The
tumor necrosis factor-alpha promoter −1031C polymorphism is
associated with decreased risk of endometriosis in a Japanese
population. Hum Reprod. 19:2509–2514. 2004.
|
|
144
|
Teramoto M, Kitawaki J, Koshiba H, et al:
Genetic contribution of tumor necrosis factor (TNF)-alpha gene
promoter (−1031, −863 and −857) and TNF receptor 2 gene
polymorphisms in endometriosis susceptibility. Am J Reprod Immunol.
51:352–357. 2004.
|
|
145
|
Christofolini DM, Cavalheiro CM, Teles JS,
et al: Promoter −817C>T variant of B lymphocyte stimulator gene
(BLyS) and susceptibility to endometriosis-related infertility and
idiopathic infertility in Brazilian population. Scand J Immunol.
74:628–631. 2011.
|
|
146
|
Lee HJ, Kim H, Ku SY, Kim SH and Kim JG:
Transforming growth factor-β1 gene polymorphisms in Korean women
with endometriosis. Am J Reprod Immunol. 66:428–434. 2011.
|
|
147
|
Hsieh YY, Chang CC, Tsai FJ, Peng CT, Yeh
LS and Lin CC: Polymorphism for transforming growth factor beta
1–509 (TGF-B1–509): association with endometriosis. Biochem Genet.
43:203–210. 2005.
|
|
148
|
Latha M, Vaidya S, Movva S, et al:
Molecular pathogenesis of endometriosis; Toll-like receptor-4 A896G
(D299G) polymorphism: a novel explanation. Genet Test Mol
Biomarkers. 15:181–184. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Tsuchiya M, Tsukino H, Iwasaki M, et al:
Interaction between cytochrome P450 gene polymorphisms and serum
organochlorine TEQ levels in the risk of endometriosis. Mol Hum
Reprod. 13:399–404. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Cayan F, Ayaz L, Aban M, Dilek S and Gümüş
LT: Role of CYP2C19 polymorphisms in patients with endometriosis.
Gynecol Endocrinol. 25:530–535. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Szczepańska M, Wirstlein P, Skrzypczak J
and Jagodziński PP: Polymorphic variants of CYP17 and CYP19A and
risk of infertility in endometriosis. Acta Obstet Gynecol Scand.
92:1188–1193. 2013.PubMed/NCBI
|
|
152
|
Bozdag G, Alp A, Saribas Z, Tuncer S, Aksu
T and Gurgan T: CYP17 and CYP2C19 gene polymorphisms in patients
with endometriosis. Reprod Biomed Online. 20:286–290. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Hsieh YY, Chang CC, Tsai FJ, Lin CC and
Tsai CH: Estrogen receptor alpha dinucleotide repeat and cytochrome
P450c17alpha gene polymorphisms are associated with susceptibility
to endometriosis. Fertil Steril. 83:567–572. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Hsieh YY, Chang CC, Tsai FJ, Lin CC and
Tsai CH: Cytochrome P450c17alpha 5’-untranslated region *T/C
polymorphism in endometriosis. J Genet. 83:189–192. 2004.
|
|
155
|
Wang HS, Wu HM, Cheng BH, et al:
Functional analyses of endometriosis-related polymorphisms in the
estrogen synthesis and metabolism-related genes. PLoS One.
7:e473742012. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Trabert B, Schwartz SM, Peters U, et al:
Genetic variation in the sex hormone metabolic pathway and
endometriosis risk: an evaluation of candidate genes. Fertil
Steril. 96:1401–1406.e3. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Vietri MT, Cioffi M, Sessa M, et al: CYP17
and CYP19 gene polymorphisms in women affected with endometriosis.
Fertil Steril. 92:1532–1535. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Kado N, Kitawaki J, Obayashi H, et al:
Association of the CYP17 gene and CYP19 gene polymorphisms with
risk of endometriosis in Japanese women. Hum Reprod. 17:897–902.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Ertunc D, Aban M, Tok EC, Tamer L, Arslan
M and Dilek S: Glutathione-S-transferase P1 gene polymorphism and
susceptibility to endometriosis. Hum Reprod. 20:2157–2161. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Tsuchiya M, Katoh T, Motoyama H, Sasaki H,
Tsugane S and Ikenoue T: Analysis of the AhR, ARNT, and AhRR gene
polymorphisms: genetic contribution to endometriosis susceptibility
and severity. Fertil Steril. 84:454–458. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Shaik NA, Govindan S, Kodati V, Rao KP and
Hasan Q: Polymorphic (CAG)n repeats in the androgen receptor gene:
a risk marker for endometriosis and uterine leiomyomas. Hematol
Oncol Stem Cell Ther. 2:289–293. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Bilibio JP, Matte U, de Conto E, Genro VK,
Souza CA and Cunha-Filho JS: Dopamine receptor D2 genotype (3438)
is associated with moderate/severe endometriosis in infertile women
in Brazil. Fertil Steril. 99:1340–1345. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Govindan S, Shaik NA, Vedicherla B, Kodati
V, Rao KP and Hasan Q: Estrogen receptor-alpha gene (T/C) Pvu II
polymorphism in endometriosis and uterine fibroids. Dis Markers.
26:149–154. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Wang W, Li Y, Maitituoheti M, Yang R, et
al: Association of an oestrogen receptor gene polymorphism in
Chinese Han women with endometriosis and endometriosis-related
infertility. Reprod Biomed Online. 26:93–98. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Lamp M, Peters M, Reinmaa E, et al:
Polymorphisms in ESR1, ESR2 and HSD17B1 genes are associated with
fertility status in endometriosis. Gynecol Endocrinol. 27:425–433.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Hsieh YY, Wang YK, Chang CC and Lin CS:
Estrogen receptor alpha-351 XbaI*G and -397 PvuII*C-related
genotypes and alleles are associated with higher susceptibilities
of endometriosis and leiomyoma. Mol Hum Reprod. 13:117–122.
2007.PubMed/NCBI
|
|
167
|
Luisi S, Galleri L, Marini F, Ambrosini G,
Brandi ML and Petraglia F: Estrogen receptor gene polymorphisms are
associated with recurrence of endometriosis. Fertil Steril.
85:764–766. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Kim SH, Choi YM, Jun JK, Kim SH, Kim JG
and Moon SY: Estrogen receptor dinucleotide repeat polymorphism is
associated with minimal or mild endometriosis. Fertil Steril.
84:774–777. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Kitawaki J, Obayashi H, Ishihara H, et al:
Oestrogen receptor-alpha gene polymorphism is associated with
endometriosis, adenomyosis and leiomyomata. Hum Reprod. 16:51–55.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Georgiou I, Syrrou M, Bouba I, et al:
Association of estrogen receptor gene polymorphisms with
endometriosis. Fertil Steril. 72:164–166. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Silva RC, Costa IR, Bordin BM, et al: RsaI
polymorphism of the ERβ gene in women with endometriosis. Genet Mol
Res. 10:465–470. 2011.
|
|
172
|
Zulli K, Bianco B, Mafra FA, Teles JS,
Christofolini DM and Barbosa CP: Polymorphism of the estrogen
receptor β gene is related to infertility and
infertility-associated endometriosis. Arq Bras Endocrinol Metabol.
54:567–571. 2010.
|
|
173
|
Bianco B, Christofolini DM, Mafra FA,
Brandes A, Zulli K and Barbosa CP: +1730 G/A polymorphism of the
estrogen receptor beta gene (ERbeta) may be an important genetic
factor predisposing to endometriosis. Acta Obstet Gynecol Scand.
88:1397–1401. 2009.
|
|
174
|
Wang Z, Yoshida S, Negoro K, Kennedy S,
Barlow D and Maruo T: Polymorphisms in the estrogen receptor beta
gene but not estrogen receptor alpha gene affect the risk of
developing endometriosis in a Japanese population. Fertil Steril.
81:1650–1656. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Tsuchiya M, Nakao H, Katoh T, et al:
Association between endometriosis and genetic polymorphisms of the
estradiol-synthesizing enzyme genes HSD17B1 and CYP19. Hum Reprod.
20:974–978. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Hu X, Zhou Y, Feng Q, et al: Association
of endometriosis risk and genetic polymorphisms involving
biosynthesis of sex steroids and their receptors: an updating
meta-analysis. Eur J Obstet Gynecol Reprod Biol. 164:1–9. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Wang HS, Cheng BH, Wu HM, et al: A mutant
single nucleotide polymorphism of follicle-stimulating hormone
receptor is associated with a lower risk of endometriosis. Fertil
Steril. 95:455–457. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Mafra FA, Bianco B, Christofolini DM,
Souza AM, Zulli K and Barbosa CP: Luteinizing hormone beta-subunit
gene (LHbeta) polymorphism in infertility and
endometriosis-associated infertility. Eur J Obstet Gynecol Reprod
Biol. 151:66–69. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Caballero V, Ruiz R, Sainz JA, et al:
Preliminary molecular genetic analysis of the receptor interacting
protein 140 (RIP140) in women affected by endometriosis. J Exp Clin
Assist Reprod. 2:112005. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Costa IR, Silva RC, Frare AB, et al:
Polymorphism of the progesterone receptor gene associated with
endometriosis in patients from Goiás, Brazil. Genet Mol Res.
10:1364–1370. 2011.PubMed/NCBI
|
|
181
|
De Carvalho CV, Nogueira-De-Souza NC,
Costa AM, et al: Genetic polymorphisms of cytochrome P450cl7alpha
(CYP17) and progesterone receptor genes (PROGINS) in the assessment
of endometriosis risk. Gynecol Endocrinol. 23:29–33.
2007.PubMed/NCBI
|
|
182
|
van Kaam KJ, Romano A, Schouten JP,
Dunselman GA and Groothuis PG: Progesterone receptor polymorphism
+331G/A is associated with a decreased risk of deep infiltrating
endometriosis. Hum Reprod. 22:129–135. 2007.
|
|
183
|
Lattuada D, Somigliana E, Viganò P,
Candiani M, Pardi G and Di Blasio AM: Genetics of endometriosis: a
role for the progesterone receptor gene polymorphism PROGINS? Clin
Endocrinol (Oxf). 61:190–194. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Wieser F, Schneeberger C, Tong D, Tempfer
C, Huber JC and Wenzl R: PROGINS receptor gene polymorphism is
associated with endometriosis. Fertil Steril. 77:309–312. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Ruiz LA, Dutil J, Ruiz A, et al:
Single-nucleotide polymorphisms in the lysyl oxidase-like protein 4
and complement component 3 genes are associated with increased risk
for endometriosis and endometriosis-associated infertility. Fertil
Steril. 96:512–515. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Trovó de Marqui AB: Genetic polymorphisms
and endometriosis: contribution of genes that regulate vascular
function and tissue remodeling. Rev Assoc Med Bras. 58:620–632.
2012.(In English, Portuguese).
|
|
187
|
Shan K, Ying W, Jian-Hui Z, Wei G, Na W
and Yan L: The function of the SNP in the MMP1 and MMP3 promoter in
susceptibility to endometriosis in China. Mol Hum Reprod.
11:423–427. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Tsai EM, Wang YS, Lin CS, et al: A
microRNA-520 mirSNP at the MMP2 gene influences susceptibility to
endometriosis in Chinese women. J Hum Genet. 58:202–209. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Cho YJ, Kim NH, Jeong KA, et al:
Association between MMP-2 and TIMP-2 gene polymorphisms and
advanced-stage endometriosis in Korean women. Am J Reprod Immunol.
69:73–84. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Saare M, Lamp M, Kaart T, et al:
Polymorphisms in MMP-2 and MMP-9 promoter regions are associated
with endometriosis. Fertil Steril. 94:1560–1563. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Shan K, Lian-Fu Z, Hui D, et al:
Polymorphisms in the promoter regions of the matrix
metalloproteinases-7, -9 and the risk of endometriosis and
adenomyosis in China. Mol Hum Reprod. 12:35–39. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Han YJ, Kim HN, Yoon JK, et al: Haplotype
analysis of the matrix metalloproteinase-9 gene associated with
advanced-stage endometriosis. Fertil Steril. 91:2324–2330. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
193
|
Borghese B, Chiche JD, Vernerey D, et al:
Genetic polymorphisms of matrix metalloproteinase 12 and 13 genes
are implicated in endometriosis progression. Hum Reprod.
23:1207–1213. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
194
|
Gonçalves-Filho RP, Brandes A,
Christofolini DM, Lerner TG, Bianco B and Barbosa CP: Plasminogen
activator inhibitor-1 4G/5G polymorphism in infertile women with
and without endometriosis. Acta Obstet Gynecol Scand. 90:473–477.
2011.PubMed/NCBI
|
|
195
|
Bedaiwy MA, Falcone T, Mascha EJ and
Casper RF: Genetic polymorphism in the fibrinolytic system and
endometriosis. Obstet Gynecol. 108:162–168. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
196
|
Kang S, Zhao XW, Wang N, Chen SC, Zhou RM
and Li Y: Association of polymorphisms of the MMP-2 and TIMP-2
genes with the risk of endometriosis in North Chinese women. Fertil
Steril. 90:2023–2029. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Zhang QY, Guan Q, Wang Y, et al: BDNF
Val66Met polymorphism is associated with Stage III-IV endometriosis
and poor in vitro fertilization outcome. Hum Reprod. 27:1668–1675.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
198
|
Kim H, Park JH, Ku SY, Kim SH, Choi YM and
Kim JG: Association between endometriosis and polymorphisms in
insulin-like growth factors (IGFs) and IGF-I receptor genes in
Korean women. Eur J Obstet Gynecol Reprod Biol. 156:87–90. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
199
|
Kim H, Ku SY, Kim SH, Choi YM and Kim JG:
Association between endometriosis and polymorphisms in insulin-like
growth factor binding protein genes in Korean women. Eur J Obstet
Gynecol Reprod Biol. 162:96–101. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Cayan F, Ertunç D, Aras-Ateş N, et al:
Association of G1057D variant of insulin receptor substrate-2 with
endometriosis. Fertil Steril. 94:1622–1626. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
201
|
Kang S, Li SZ, Wang N, et al: Association
between genetic polymorphisms in fibroblast growth factor (FGF)1
and FGF2 and risk of endometriosis and adenomyosis in Chinese
women. Hum Reprod. 25:1806–1811. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
202
|
Hsieh YY, Chang CC, Tsai FJ, Lin CC and
Tsai CH: T homozygote and allele of epidermal growth factor
receptor 2073 gene polymorphism are associated with higher
susceptibility to endometriosis and leiomyomas. Fertil Steril.
83:796–799. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
203
|
Vanaja MC, Rozati R, Nassaruddin K and
Vishnupriya S: Association of VEGF +405G>C polymorphism with
endometriosis. Front Biosci (Elite Ed). 5:748–754. 2013.
|
|
204
|
Xu S, Wu W, Sun H, et al: Association of
the vascular endothelial growth factor gene polymorphisms (-460C/T,
+405G/C and +936T/C) with endometriosis: a meta-analysis. Ann Hum
Genet. 76:464–471. 2012.
|
|
205
|
Emamifar B, Salehi Z, Mehrafza M and
Mashayekhi F: The vascular endothelial growth factor (VEGF)
polymorphisms and the risk of endometriosis in northern Iran.
Gynecol Endocrinol. 28:447–450. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
206
|
Lamp M, Saare M, Laisk T, et al: Genetic
variations in vascular endothelial growth factor but not in
angiotensin I-converting enzyme genes are associated with
endometriosis in Estonian women. Eur J Obstet Gynecol Reprod Biol.
153:85–89. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
207
|
Attar R, Agachan B, Kuran SB, et al:
Genetic variants of vascular endothelial growth factor and risk for
the development of endometriosis. In Vivo. 24:297–301.
2010.PubMed/NCBI
|
|
208
|
Liu Q, Li Y, Zhao J, et al: Association of
polymorphisms −1154G/A and −2578C/A in the vascular endothelial
growth factor gene with decreased risk of endometriosis in Chinese
women. Hum Reprod. 24:2660–2666. 2009.
|
|
209
|
Kim SH, Choi YM, Choung SH, Jun JK, Kim JG
and Moon SY: Vascular endothelial growth factor gene +405 C/G
polymorphism is associated with susceptibility to advanced stage
endometriosis. Hum Reprod. 20:2904–2908. 2005.
|
|
210
|
Bhanoori M, Arvind Babu K, Pavankumar
Reddy NG, et al: The vascular endothelial growth factor (VEGF)
+405G>C 5′-untranslated region polymorphism and increased risk
of endometriosis in South Indian women: a case control study. Hum
Reprod. 20:1844–1849. 2005.
|
|
211
|
Hsieh YY, Chang CC, Tsai FJ, Yeh LS, Lin
CC and Peng CT: T allele for VEGF gene-460 polymorphism at the
5′-untranslated region: association with a higher susceptibility to
endometriosis. J Reprod Med. 49:468–472. 2004.PubMed/NCBI
|
|
212
|
Kang S, Shi YY, Li Y, et al: Association
between genetic variants of the VEGFR-2 gene and the risk of
developing endometriosis in Northern Chinese Women. Gynecol Obstet
Invest. 76:32–37. 2013.PubMed/NCBI
|
|
213
|
Camargo-Kosugi CM, da Silva ID, Sato H, et
al: The V109G polymorphism in the p27 gene is associated with
endometriosis. Eur J Obstet Gynecol Reprod Biol. 145:180–183. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
214
|
Pagliardini L, Gentilini D, Vigano’ P, et
al: An Italian association study and meta-analysis with previous
GWAS confirm WNT4, CDKN2BAS and FN1 as the first identified
susceptibility loci for endometriosis. J Med Genet. 50:43–46. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
215
|
Uno S, Zembutsu H, Hirasawa A, et al: A
genome-wide association study identifies genetic variants in the
CDKN2BAS locus associated with endometriosis in Japanese. Nat
Genet. 42:707–710. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
216
|
Shi S, Zhou B, Zhang K and Zhang L:
Association between two single nucleotide polymorphisms of PDCD6
gene and increased endometriosis risk. Hum Immunol. 74:215–218.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
217
|
Gomes FM, Bianco B, Teles JS, et al:
PTPN22 C1858T polymorphism in women with endometriosis. Am J Reprod
Immunol. 63:227–232. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
218
|
Ammendola M, Bottini N, Pietropolli A,
Saccucci P and Gloria-Bottini F: Association between PTPN22 and
endometriosis. Fertil Steril. 89:993–994. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
219
|
Paskulin DD, Cunha-Filho JS, Souza CA,
Bortolini MC, Hainaut P and Ashton-Prolla P: TP53 PIN3 and PEX4
polymorphisms and infertility associated with endometriosis or with
post-in vitro fertilization implantation failure. Cell Death Dis.
3:e3922012. View Article : Google Scholar : PubMed/NCBI
|
|
220
|
Gallegos-Arreola MP, Valencia-Rodríguez
LE, Puebla-Pérez AM, Figuera LE and Zúñiga-González GM: The TP53
16-bp duplication polymorphism is enriched in endometriosis
patients. Gynecol Obstet Invest. 73:118–123. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
221
|
Jia S, Xu L, Chan Y, et al: p53 codon 72
polymorphism and endometriosis: a meta-analysis. Arch Gynecol
Obstet. 285:1657–1661. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
222
|
Ribeiro Júnior CL, Arruda JT, Silva CT and
Moura KK: Analysis of p53 codon 72 gene polymorphism in Brazilian
patients with endometriosis. Genet Mol Res. 8:494–499.
2009.PubMed/NCBI
|
|
223
|
Hsieh YY and Lin CS: P53 codon 11, 72, and
248 gene polymorphisms in endometriosis. Int J Biol Sci. 2:188–193.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
224
|
Chang CC, Hsieh YY, Tsai FJ, Tsai CH, Tsai
HD and Lin CC: The proline form of p53 codon 72 polymorphism is
associated with endometriosis. Fertil Steril. 77:43–45. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
225
|
Bhanoori M, Deenadayal M, Kennedy S and
Shivaji S: The G2964A 3′-untranslated region polymorphism of the
signal transducer and activator of transcription 6 gene is
associated with endometriosis in South Indian women. Hum Reprod.
22:1026–1030. 2007.
|
|
226
|
Yoshida K, Yoshihara K, Adachi S, et al:
Possible involvement of the E-cadherin gene in genetic
susceptibility to endometriosis. Hum Reprod. 27:1685–1689. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
227
|
Govatati S, Tangudu NK, Deenadayal M,
Chakravarty B, Shivaji S and Bhanoori M: Association of E-cadherin
single nucleotide polymorphisms with the increased risk of
endometriosis in Indian women. Mol Hum Reprod. 18:280–287. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
228
|
Shan K, Xiao-Wei M, Na W, et al:
Association of three single nucleotide polymorphisms of the
E-cadherin gene with endometriosis in a Chinese population.
Reproduction. 134:373–378. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
229
|
Aghajanpour L, Mashayekhi F and Rajaei F:
Intercellular adhesion molecule-1 (ICAM-1) gene polymorphism and
endometriosis in northern Iran. Arch Gynecol Obstet. 283:1035–1039.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
230
|
Chang CY, Chen Y, Lin WC, et al: MUC2
polymorphisms are associated with endometriosis development and
infertility: a case-control study. BMC Med Genet. 13:152012.
View Article : Google Scholar : PubMed/NCBI
|
|
231
|
Chang CY, Chang HW, Chen CM, et al: MUC4
gene polymorphisms associate with endometriosis development and
endometriosis-related infertility. BMC Med. 9:192011. View Article : Google Scholar : PubMed/NCBI
|
|
232
|
Falconer H, Sundqvist J, Xu H, et al:
Analysis of common variations in tumor-suppressor genes on chr1p36
among Caucasian women with endometriosis. Gynecol Oncol.
127:398–402. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
233
|
Wu HH, Wang NM, Lin CY and Tsai HD:
Genetic alterations of HOXA10 and their effect on the severity of
endometriosis in a Taiwanese population. Reprod Biomed Online.
16:416–424. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
234
|
Hwang KR, Choi YM, Kim JM, et al:
Association of peroxisome proliferator-activated receptor-gamma 2
Pro12Ala polymorphism with advanced-stage endometriosis. Am J
Reprod Immunol. 64:333–338. 2010.PubMed/NCBI
|
|
235
|
Kiyomizu M, Kitawaki J, Obayashi H, et al:
Association of two polymorphisms in the peroxisome
proliferator-activated receptor-gamma gene with adenomyosis,
endometriosis, and leiomyomata in Japanese women. J Soc Gynecol
Investig. 13:372–377. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
236
|
Ishii K, Takakuwa K, Kashima K, Tamura M
and Tanaka K: Associations between patients with endometriosis and
HLA class II; the analysis of HLA-DQB1 and HLA-DPB1 genotypes. Hum
Reprod. 18:985–989. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
237
|
Ishii K, Takakuwa K, Mitsui T and Tanaka
K: Studies on the human leukocyte antigen-DR in patients with
endometriosis: genotyping of HLA-DRB1 alleles. Hum Reprod.
17:560–563. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
238
|
Grechukhina O, Petracco R, Popkhadze S, et
al: A polymorphism in a let-7 microRNA binding site of KRAS in
women with endometriosis. EMBO Mol Med. 4:206–217. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
239
|
Hsieh YY, Lee CC, Chang CC, Wang YK, Yeh
LS and Lin CS: Angiotensin I-converting enzyme insertion-related
genotypes and allele are associated with higher susceptibility of
endometriosis and leiomyoma. Mol Reprod Dev. 74:808–814. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
240
|
Hsieh YY, Chang CC, Tsai FJ, Hsu CM, Lin
CC and Tsai CH: Angiotensin I-converting enzyme ACE 2350*G and
ACE-240*T-related genotypes and alleles are associated with higher
susceptibility to endometriosis. Mol Hum Reprod. 11:11–14.
2005.
|
|
241
|
Kim JG, Kim H, Ku SY, et al: Association
between human alpha 2-Heremans Schmidt glycoprotein (AHSG)
polymorphism and endometriosis in Korean women. Fertil Steril.
82:1497–1500. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
242
|
Borghese B, Santulli P, Héquet D, et al:
Genetic polymorphisms of DNMT3L involved in hypermethylation of
chromosomal ends are associated with greater risk of developing
ovarian endometriosis. Am J Pathol. 180:1781–1786. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
243
|
Szczepańska M, Mostowska A, Wirstlein P,
et al: Polymorphic variants of folate and choline metabolism genes
and the risk of endometriosis-associated infertility. Eur J Obstet
Gynecol Reprod Biol. 157:67–72. 2011.PubMed/NCBI
|
|
244
|
Zhao ZZ, Croft L, Nyholt DR, et al:
Evaluation of polymorphisms in predicted target sites for micro
RNAs differentially expressed in endometriosis. Mol Hum Reprod.
17:92–103. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
245
|
Chun S, Kim H, Ku SY, Suh CS, Kim SH and
Kim JG: The association between endometriosis and polymorphisms in
the interleukin-1 family genes in Korean women. Am J Reprod
Immunol. 68:154–163. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
246
|
Viganò P, Infantino M, Lattuada D, et al:
Intercellular adhesion molecule-1 (ICAM-1) gene polymorphisms in
endometriosis. Mol Hum Reprod. 9:47–52. 2003.
|
